Frequency of T790M mutations after progression on epidermal growth factor receptor tyrosine kinase inhibitor in metastatic non-small cell lung cancer in Indian patients: real-time data from tertiary cancer hospital

AIM: The aim of this study is to determine the incidence of T790M mutations after progression on epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) and median duration on TKI before progression on TKI. METHODS: Records of Rajiv Gandhi Cancer Institute and Research Centre, of pa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lung India
Main Authors: Babu Koyyala, Venkata Pradeep, Batra, Ullas, Jain, Parveen, Sharma, Mansi, Goyal, Pankaj, Medisetty, Pavani, Jajodia, Ankush, Maheshwari, Udip Dilip
Formato: Artigo
Idioma:Inglês
Publicado em: Medknow Publications & Media Pvt Ltd 2018
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6120311/
https://ncbi.nlm.nih.gov/pubmed/30168457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/lungindia.lungindia_451_17
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados